Coral Laboratories

625.50
-33.15
(-5.03%)
Market Cap
223.27 Cr
EPS
44.19
PE Ratio
8.65
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
999.00
52 Week Low
355.00
PB Ratio
1.16
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,687.55
#1 4,04,899.77
33.61
#1 49,887.20
12.06
#1 9,648
13.77
47.60
5,589.30
1,48,378.35
69.15
8,184.00
0.89
1,600
#1 64.53
47.92
1,463.05
1,18,158.10
22.92
26,520.70
14.17
4,155
47.38
50.89
3,129.00
1,05,899.58
56.83
10,785.70
11.59
1,656
13.54
45.29
2,350.50
96,976.58
46.77
10,615.60
19.57
1,942
-16.38
48.68
1,109.50
92,582.82
#1 17.01
28,905.40
12.36
5,578
1.69
40.66
1,969.25
89,904.33
30.58
20,141.50
#1 19.94
1,936
38.82
46.62
868.85
87,426.64
18.74
19,831.50
13.82
3,831
29.92
44.56
29,641.10
62,985.27
46.40
6,097.20
10.80
1,201
16.01
48.36
1,082.45
62,868.87
17.41
29,559.20
17.55
3,169
-10.04
41.61
Growth Rate
Revenue Growth
6.24 %
Net Income Growth
146.88 %
Cash Flow Change
-143.09 %
ROE
113.94 %
ROCE
117.65 %
EBITDA Margin (Avg.)
101.19 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
62
80
99
97
96
77
100
80
85
90
125
Expenses
47
61
72
77
79
65
81
67
74
67
86
EBITDA
15
19
27
20
17
11
20
13
11
23
39
Operating Profit %
21 %
21 %
24 %
16 %
13 %
8 %
16 %
11 %
5 %
19 %
26 %
Depreciation
3
2
2
2
2
2
2
2
2
2
2
Interest
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
12
17
25
18
16
9
18
12
8
21
36
Tax
3
5
8
6
5
2
4
3
2
5
9
Net Profit
10
12
16
12
10
7
14
9
6
16
27
EPS in ₹
26.79
34.70
45.61
34.84
28.60
19.96
37.94
25.32
18.04
44.19
75.90

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
72
90
131
140
136
144
168
190
174
206
Fixed Assets
19
18
18
22
23
23
21
24
25
24
Current Assets
50
65
74
72
84
96
129
131
124
154
Capital Work in Progress
0
0
0
0
0
0
1
2
0
0
Investments
0
0
39
45
28
25
33
46
41
50
Other Assets
54
71
74
73
85
97
112
118
108
132
Total Liabilities
72
90
131
140
136
144
168
190
174
206
Current Liabilities
12
18
19
20
18
25
28
26
12
25
Non Current Liabilities
1
1
4
4
4
4
3
8
8
3
Total Equity
59
70
109
116
114
116
137
156
155
178
Reserve & Surplus
56
67
106
113
110
112
133
153
151
174
Share Capital
4
4
4
4
4
4
4
4
4
4

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
2
2
-2
1
-2
1
0
4
-4
Investing Activities
-1
-3
-10
-13
3
-2
-0
-6
-3
1
Operating Activities
0
5
11
14
-1
-4
1
6
13
-6
Financing Activities
0
-0
1
-3
-1
4
0
0
-6
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
71.51 %
71.51 %
71.51 %
71.51 %
71.51 %
71.51 %
71.51 %
71.51 %
71.51 %
71.51 %
71.51 %
71.51 %
71.51 %
71.51 %
71.51 %
71.51 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.14 %
0.14 %
0.14 %
0.23 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
22.40 %
21.93 %
22.55 %
21.87 %
21.50 %
21.34 %
21.01 %
20.85 %
21.24 %
21.16 %
20.90 %
20.87 %
20.82 %
20.33 %
21.18 %
20.99 %
Others
6.09 %
6.56 %
5.94 %
6.62 %
6.99 %
7.15 %
7.48 %
7.64 %
7.25 %
7.33 %
7.44 %
7.48 %
7.52 %
7.93 %
7.31 %
7.50 %
No of Share Holders
0
3,936
4,020
4,237
4,425
4,388
4,317
4,218
4,046
4,040
3,981
4,005
4,098
3,831
3,949
4,054

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 5 2 2 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.84 0.63 2.04 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20186 days ago
Closure of Trading WindowMar 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2025
Integrated Filing (Financial)Feb 13, 2025
To Consider And Adopt The Unaudited Standalone Financial Results For The Quarter And Nine Months Ended December 31 2024 With The Limited Review ReportFeb 13, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On February 13 2025 Pursuant To Regulation 30 (Read With Part A Of Schedule III) The SEBI (Listing Obligations And Disclosure Requirements) Feb 13, 2025
Board Meeting Intimation for Considering Approving And Taking On Record The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024Feb 05, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Change Of Name Of Registrar And Share Transfer Agent Of The CompanyJan 03, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 31, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 27, 2024
Submission Of Limited Review Report Missed Inadvertently In Financial Result Submitted On 14Th November, 2024Nov 26, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2024
Disclosure Under Reg 23(9) Of SEBI (LODR) Regulations, 2015Nov 14, 2024
Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30, 2024, As Per Regulation 33 Under SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015Nov 14, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14, 2024, Pursuant To Regulation 30 (Read With Part A Of Schedule III) The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)Nov 14, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 09, 2024
Board Meeting Intimation for Notice Under Regulation 29(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015Nov 06, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 10, 2024
Submission Of Annual Report For The Financial Year 2023-24 As Duly Approved By The Members Of The CompanySep 28, 2024
Voting Results Under Regulation 44 Of SEBI LODR Regulations, 2015Sep 28, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 28, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2024
Closure of Trading WindowSep 25, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On September 24, 2024, Pursuant To Regulation 30 (Read With Part A Of Schedule III) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015Sep 24, 2024
Board Meeting Intimation for Approval Of Cost Audit Report In Form CRA-3 For The Financial Year 2023-2024Sep 19, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 13, 2024
Communication To Shareholders - Intimation On Tax Deduction On DividendSep 10, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2024
Notice Convening The 42Nd Annual General Meeting (AGM) And The Annual Report For Financial Year 2023-24Sep 05, 2024
Reg. 34 (1) Annual Report.Sep 05, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 16, 2024
Corrigendum To Announcement Intimation Of Financial Results For Quarter Ended June 30, 2024Aug 14, 2024
Regulation 42 Under The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Aug 14, 2024
Notice Of Book Closure & Record DateAug 14, 2024
Intimation For Holding 42Nd Annual General MeetingAug 14, 2024
Submission Of Standalone Unaudited Financial Results Of Coral Laboratories Limited For The Quarter Ended June 30, 2023 Along With Limited Review Report.Aug 14, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 14, 2024 Pursuant To Reg 30 (ReadWith Part A Of Schedule III) Of The SEBI (Listing Obligations And DisclosureRequirements) Regulations, 2015Aug 14, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementAug 09, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 09, 2024 Pursuant To Reg 30 (Read With Part A Of Schedule III) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Aug 09, 2024
Board Meeting Intimation for Meeting Scheduled To Be Held On August 14, 2024.Aug 06, 2024
Board Meeting Intimation for Meeting Scheduled To Be Held On August 09, 2024Aug 06, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 02, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 17, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 17, 2024
Appointment Of Internal AuditorJul 13, 2024
Appointment of Company Secretary and Compliance OfficerJul 13, 2024
Corporate Action-Board approves DividendJul 13, 2024
Board Meeting Outcome for Outcome Of Board MeetingJul 13, 2024

Technical Indicators

RSI(14)
Neutral
31.38
ATR(14)
Volatile
34.04
STOCH(9,6)
Neutral
28.90
STOCH RSI(14)
Neutral
31.25
MACD(12,26)
Bearish
-7.39
ADX(14)
Strong Trend
31.08
UO(9)
Bearish
34.06
ROC(12)
Downtrend And Accelerating
-14.46
WillR(14)
Oversold
-96.19